Unbelievable. This review totally ignored the gran
Post# of 148240
https://www.pharmacytimes.com/news/monoclonal...oronavirus
"There are currently 4 novel mAb agents in phase 3 for the treatment or prevention of COVID-19, which include REGN-CoV-2, lenzilumab, and ravulizumab. Two of these agents have been issued Emergency Use Authorizations (EUAs), but are awaiting FDA approval."